Light/dark patterns of interleukin-6 in relation to the pineal hormone melatonin in patients with acute myocardial infarction

Alberto Dominguez-Rodriguez, Pedro Abreu-Gonzalez, Martin Garcia, Julio Ferrer, Alejandro De La Rosa, Manuel Vargas, Russel J Reiter

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

Aims Atherosclerosis is a chronic disease that, from its origin to its ultimate complications, involves inflammatory cells, inflammatory proteins, and inflammatory responses from vascular cells. It has been demonstrated that cytokine activities are under neuroendocrine control, in part exerted by the pineal gland through the circadian secretion of its main product melatonin. Melatonin is mainly released during the night, but the precise relationship between melatonin and the light/dark rhythm of interleukin-6 in patients with acute myocardial infarction is still unclear. Methods and results The study included 60 patients diagnosed with acute myocardial infarction and 60 healthy volunteers whose venous blood samples were collected at 09:00 h (light period) and 02:00 h (dark period). Our results demonstrate that interleukin-6 concentrations presented a light/dark pattern with mean serum concentrations being higher in the acute myocardial infarction group than in the control group (101.26±13.43 and 52.67±7.73pg/ml at 02:00 h, 41.93±5.90 and 22.98±4.49pg/ml at 09:00 h, respectively, p<0.05). Differences in the day/night changes in melatonin levels in control subjects (48.19±7. 82 at 02:00 h, 14.51±2.36 at 09:00 h, pg/ml) and acute myocardial infarction patients (25.97±3.90 at 02:00 h, 12.29±4.01 at 09:00 h, pg/ml) (p<0.05) were a result of a reduced nocturnal elevation of melatonin in the acute myocardial infarction group. Conclusions The current findings suggest that the circadian secretion of melatonin may be responsible at least in part for light/dark variations of endogenous interleukin-6 production in patients with acute myocardial infarction. In this study, the melatonin seems to have an anti-inflammatory effect.

Original languageEnglish (US)
Pages (from-to)89-93
Number of pages5
JournalCytokine
Volume26
Issue number2
DOIs
StatePublished - Apr 21 2004
Externally publishedYes

Fingerprint

Melatonin
Interleukin-6
Myocardial Infarction
Hormones
Light
Pineal Gland
Blood Vessels
Atherosclerosis
Healthy Volunteers
Blood
Chronic Disease
Anti-Inflammatory Agents
Cytokines
Control Groups
Serum
Proteins

Keywords

  • Anti-inflammatory
  • Interleukin
  • Light-dark
  • Melatonin
  • Myocardial infarction

ASJC Scopus subject areas

  • Endocrinology
  • Molecular Biology
  • Immunology
  • Immunology and Allergy

Cite this

Light/dark patterns of interleukin-6 in relation to the pineal hormone melatonin in patients with acute myocardial infarction. / Dominguez-Rodriguez, Alberto; Abreu-Gonzalez, Pedro; Garcia, Martin; Ferrer, Julio; De La Rosa, Alejandro; Vargas, Manuel; Reiter, Russel J.

In: Cytokine, Vol. 26, No. 2, 21.04.2004, p. 89-93.

Research output: Contribution to journalArticle

Dominguez-Rodriguez, A, Abreu-Gonzalez, P, Garcia, M, Ferrer, J, De La Rosa, A, Vargas, M & Reiter, RJ 2004, 'Light/dark patterns of interleukin-6 in relation to the pineal hormone melatonin in patients with acute myocardial infarction', Cytokine, vol. 26, no. 2, pp. 89-93. https://doi.org/10.1016/j.cyto.2004.01.003
Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia M, Ferrer J, De La Rosa A, Vargas M et al. Light/dark patterns of interleukin-6 in relation to the pineal hormone melatonin in patients with acute myocardial infarction. Cytokine. 2004 Apr 21;26(2):89-93. https://doi.org/10.1016/j.cyto.2004.01.003
Dominguez-Rodriguez, Alberto ; Abreu-Gonzalez, Pedro ; Garcia, Martin ; Ferrer, Julio ; De La Rosa, Alejandro ; Vargas, Manuel ; Reiter, Russel J. / Light/dark patterns of interleukin-6 in relation to the pineal hormone melatonin in patients with acute myocardial infarction. In: Cytokine. 2004 ; Vol. 26, No. 2. pp. 89-93.
@article{0bb370274f674e08847fd749961d29d9,
title = "Light/dark patterns of interleukin-6 in relation to the pineal hormone melatonin in patients with acute myocardial infarction",
abstract = "Aims Atherosclerosis is a chronic disease that, from its origin to its ultimate complications, involves inflammatory cells, inflammatory proteins, and inflammatory responses from vascular cells. It has been demonstrated that cytokine activities are under neuroendocrine control, in part exerted by the pineal gland through the circadian secretion of its main product melatonin. Melatonin is mainly released during the night, but the precise relationship between melatonin and the light/dark rhythm of interleukin-6 in patients with acute myocardial infarction is still unclear. Methods and results The study included 60 patients diagnosed with acute myocardial infarction and 60 healthy volunteers whose venous blood samples were collected at 09:00 h (light period) and 02:00 h (dark period). Our results demonstrate that interleukin-6 concentrations presented a light/dark pattern with mean serum concentrations being higher in the acute myocardial infarction group than in the control group (101.26±13.43 and 52.67±7.73pg/ml at 02:00 h, 41.93±5.90 and 22.98±4.49pg/ml at 09:00 h, respectively, p<0.05). Differences in the day/night changes in melatonin levels in control subjects (48.19±7. 82 at 02:00 h, 14.51±2.36 at 09:00 h, pg/ml) and acute myocardial infarction patients (25.97±3.90 at 02:00 h, 12.29±4.01 at 09:00 h, pg/ml) (p<0.05) were a result of a reduced nocturnal elevation of melatonin in the acute myocardial infarction group. Conclusions The current findings suggest that the circadian secretion of melatonin may be responsible at least in part for light/dark variations of endogenous interleukin-6 production in patients with acute myocardial infarction. In this study, the melatonin seems to have an anti-inflammatory effect.",
keywords = "Anti-inflammatory, Interleukin, Light-dark, Melatonin, Myocardial infarction",
author = "Alberto Dominguez-Rodriguez and Pedro Abreu-Gonzalez and Martin Garcia and Julio Ferrer and {De La Rosa}, Alejandro and Manuel Vargas and Reiter, {Russel J}",
year = "2004",
month = "4",
day = "21",
doi = "10.1016/j.cyto.2004.01.003",
language = "English (US)",
volume = "26",
pages = "89--93",
journal = "Cytokine",
issn = "1043-4666",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Light/dark patterns of interleukin-6 in relation to the pineal hormone melatonin in patients with acute myocardial infarction

AU - Dominguez-Rodriguez, Alberto

AU - Abreu-Gonzalez, Pedro

AU - Garcia, Martin

AU - Ferrer, Julio

AU - De La Rosa, Alejandro

AU - Vargas, Manuel

AU - Reiter, Russel J

PY - 2004/4/21

Y1 - 2004/4/21

N2 - Aims Atherosclerosis is a chronic disease that, from its origin to its ultimate complications, involves inflammatory cells, inflammatory proteins, and inflammatory responses from vascular cells. It has been demonstrated that cytokine activities are under neuroendocrine control, in part exerted by the pineal gland through the circadian secretion of its main product melatonin. Melatonin is mainly released during the night, but the precise relationship between melatonin and the light/dark rhythm of interleukin-6 in patients with acute myocardial infarction is still unclear. Methods and results The study included 60 patients diagnosed with acute myocardial infarction and 60 healthy volunteers whose venous blood samples were collected at 09:00 h (light period) and 02:00 h (dark period). Our results demonstrate that interleukin-6 concentrations presented a light/dark pattern with mean serum concentrations being higher in the acute myocardial infarction group than in the control group (101.26±13.43 and 52.67±7.73pg/ml at 02:00 h, 41.93±5.90 and 22.98±4.49pg/ml at 09:00 h, respectively, p<0.05). Differences in the day/night changes in melatonin levels in control subjects (48.19±7. 82 at 02:00 h, 14.51±2.36 at 09:00 h, pg/ml) and acute myocardial infarction patients (25.97±3.90 at 02:00 h, 12.29±4.01 at 09:00 h, pg/ml) (p<0.05) were a result of a reduced nocturnal elevation of melatonin in the acute myocardial infarction group. Conclusions The current findings suggest that the circadian secretion of melatonin may be responsible at least in part for light/dark variations of endogenous interleukin-6 production in patients with acute myocardial infarction. In this study, the melatonin seems to have an anti-inflammatory effect.

AB - Aims Atherosclerosis is a chronic disease that, from its origin to its ultimate complications, involves inflammatory cells, inflammatory proteins, and inflammatory responses from vascular cells. It has been demonstrated that cytokine activities are under neuroendocrine control, in part exerted by the pineal gland through the circadian secretion of its main product melatonin. Melatonin is mainly released during the night, but the precise relationship between melatonin and the light/dark rhythm of interleukin-6 in patients with acute myocardial infarction is still unclear. Methods and results The study included 60 patients diagnosed with acute myocardial infarction and 60 healthy volunteers whose venous blood samples were collected at 09:00 h (light period) and 02:00 h (dark period). Our results demonstrate that interleukin-6 concentrations presented a light/dark pattern with mean serum concentrations being higher in the acute myocardial infarction group than in the control group (101.26±13.43 and 52.67±7.73pg/ml at 02:00 h, 41.93±5.90 and 22.98±4.49pg/ml at 09:00 h, respectively, p<0.05). Differences in the day/night changes in melatonin levels in control subjects (48.19±7. 82 at 02:00 h, 14.51±2.36 at 09:00 h, pg/ml) and acute myocardial infarction patients (25.97±3.90 at 02:00 h, 12.29±4.01 at 09:00 h, pg/ml) (p<0.05) were a result of a reduced nocturnal elevation of melatonin in the acute myocardial infarction group. Conclusions The current findings suggest that the circadian secretion of melatonin may be responsible at least in part for light/dark variations of endogenous interleukin-6 production in patients with acute myocardial infarction. In this study, the melatonin seems to have an anti-inflammatory effect.

KW - Anti-inflammatory

KW - Interleukin

KW - Light-dark

KW - Melatonin

KW - Myocardial infarction

UR - http://www.scopus.com/inward/record.url?scp=1642619150&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642619150&partnerID=8YFLogxK

U2 - 10.1016/j.cyto.2004.01.003

DO - 10.1016/j.cyto.2004.01.003

M3 - Article

VL - 26

SP - 89

EP - 93

JO - Cytokine

JF - Cytokine

SN - 1043-4666

IS - 2

ER -